JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PUT
UnitedHealth
UNH
$371B
| $52.2M | 0.01% |
212,000
+120,900
| +133% | +$29.1M |
|
927
McCormick & Company Non-Voting
MKC
$14.3B
| $52.1M | 0.01% |
669,068
+298,636
| +81% | +$23M |
|
|
INXN
928
DELISTED
Interxion Holding N.V.
INXN
| $52.1M | 0.01% |
694,539
+140,653
| +25% | +$10M |
|
929
Texas Roadhouse
TXRH
$13.6B
| $52.1M | 0.01% |
957,199
+74,010
| +8% | +$4.16M |
|
930
Nektar Therapeutics
NKTR
$2.53B
| $52.1M | 0.01% |
100,118
-44,917
| -31% | -$22.5M |
|
|
BDXA
931
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $52M | 0.01% |
839,706
-24,277
| -3% | -$1.44M |
|
|
932
CALL
AT&T
T
$165B
| $51.8M | 0.01% |
2,080,401
-975,126
| -32% | -$23.4M |
|
933
Tenet Healthcare
THC
$20.9B
| $51.7M | 0.01% |
2,547,080
-428,931
| -14% | -$9.89M |
|
934
PUT
Comcast
CMCSA
$89.4B
| $51.7M | 0.01% |
1,230,000
+1,200,000
| +4,000% | +$50.6M |
|
|
CY
935
DELISTED
Cypress Semiconductor
CY
| $51.6M | 0.01% |
2,324,651
+580,439
| +33% | +$10.5M |
|
936
iShares MSCI USA Value Factor ETF
VLUE
$9.46B
| $51.5M | 0.01% |
640,919
-4,199,154
| -87% | -$336M |
|
937
CALL
Bank of America
BAC
$447B
| $51.5M | 0.01% |
1,824,300
+83,300
| +5% | +$2.4M |
|
938
Trustmark
TRMK
$2.75B
| $51.4M | 0.01% |
1,571,812
+28,432
| +2% | +$961K |
|
939
PUT
Blackstone
BX
$113B
| $51.4M | 0.01% |
1,160,300
+465,300
| +67% | +$18.6M |
|
940
Ovintiv
OVV
$17.6B
| $51.4M | 0.01% |
2,051,177
+1,399,872
| +215% | +$43.7M |
|
|
TCF
941
DELISTED
TCF Financial Corporation
TCF
| $51.3M | 0.01% |
2,513,193
-48,563
| -2% | -$1.01M |
|
942
Agilent Technologies
A
$42B
| $51.2M | 0.01% |
699,366
-82,845
| -11% | -$6.14M |
|
|
MDRX
943
DELISTED
Veradigm Inc. Common Stock
MDRX
| $51.1M | 0.01% |
4,465,650
+3,057,330
| +217% | +$31.1M |
|
944
Fortinet
FTNT
$120B
| $51.1M | 0.01% |
3,330,505
+644,145
| +24% | +$10.6M |
|
945
PUT
Itaú Unibanco
ITUB
$86.9B
| $50.6M | 0.01% |
7,400,762
-563,475
| -7% | -$3.55M |
|
946
PUT
Bristol-Myers Squibb
BMY
$132B
| $50.5M | 0.01% |
1,120,800
-838,500
| -43% | -$39.1M |
|
947
PUT
Amgen
AMGN
$226B
| $50.4M | 0.01% |
274,100
-29,500
| -10% | -$5.28M |
|
948
Cirrus Logic
CRUS
$6.11B
| $50.2M | 0.01% |
1,159,186
-85,266
| -7% | -$3.7M |
|
949
PUT
Texas Instruments
TXN
$256B
| $50.1M | 0.01% |
432,700
+64,400
| +17% | +$7.2M |
|
|
WWE
950
DELISTED
World Wrestling Entertainment
WWE
| $49.8M | 0.01% |
689,682
-268,497
| -28% | -$22M |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.